Published in Hepatitis Weekly, February 3rd, 1997
"Since fatal flutamide-related hepatitis has been reported, monitoring of serum liver tests is advocated during flutamide administration, and the effectiveness of UDCA in the treatment of drug-induced hepatoxicity requires further study," researcher Camilla Cicognani and colleagues wrote ("Flutamide-Induced Toxic Hepatitis," Digestive Diseases and Sciences, November 1996;41(11):2219-2221).
Flutamide (4' nitro-3'-trifluoromethyl-isobutylanilide) is a nonsteroidal antiandrogen commonly used in the treatment of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly